Bioneer Corporation · KRX:064550

Bioneer Corporation financial statements

Bioneer Corporation's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue330.1B294.0B263.2B218.4B223.7B207.0B36.3B24.1B23.3B21.7B
Cost of revenue72.9B74.1B60.2B51.7B49.5B44.4B17.1B11.1B9.65B10.2B
Gross profit257.2B219.9B203.0B166.6B174.2B162.6B19.2B12.9B13.6B11.5B
Research and development12.8B19.2B15.0B16.8B18.0B13.1B10.4B8.07B8.47B
Selling, general and administrative196.5B210.0B183.4B135.1B107.1B41.4B13.4B11.8B9.00B13.3B
Operating income14.1B-13.6B826.9M11.6B47.1B103.9B-9.41B-13.6B-7.11B-12.5B
Depreciation and amortization8.97B8.05B8.10B7.27B5.85B5.38B5.27B4.99B3.90B1.35B
EBITDA23.1B-5.51B8.93B18.9B53.0B109.2B-4.14B-8.64B-3.20B-11.2B
Interest expense4.61B3.42B1.41B647.9M641.4M2.00B0000
Income before tax9.90B-15.3B-67.0M13.9B43.3B55.7B-6.37B-10.0B-9.71B-14.1B
Income tax14.1B-3.54B1.05B-1.23B168.2M357.3M
Net income-2.81B-20.6B-10.6B12.1B27.2B57.9B-7.83B-8.82B-9.87B-14.4B
Earnings per share, basic-108.99-797.52-410.19467.911,052.282,296.53-351.59-427.59-478.79-832.65

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents47.7B40.0B48.5B43.8B49.4B32.7B4.74B4.01B4.36B2.90B
Short-term investments44.8B54.2B43.3B36.2B33.2B27.2B20.5B800.0M4.94B1.99B
Receivables12.5B14.1B9.86B13.2B19.6B11.6B4.62B5.45B6.64B7.95B
Inventory37.7B37.4B41.4B38.0B26.5B18.3B10.2B8.17B8.91B7.85B
Current assets148.8B148.5B147.7B134.1B136.4B95.1B43.0B31.2B27.1B23.1B
Property, plant and equipment151.5B113.5B83.0B31.8B29.6B19.5B19.8B
Total assets369.9B332.2B315.5B298.7B262.4B191.2B82.1B70.8B58.7B63.7B
Accounts payable1.67B2.69B1.82B2.22B4.05B2.35B1.28B1.77B1.54B2.19B
Current liabilities66.1B65.6B53.7B36.2B50.8B34.8B36.0B24.2B20.2B26.1B
Long-term debt60.1B25.9B12.5B7.47B06.90B9.41B1.84B5.24B5.45B
Total debt7.39B13.8B6.74B10.5B12.6B
Total liabilities142.9B105.3B80.6B62.7B59.4B45.6B51.5B31.8B31.5B37.6B
Shareholders' equity209.7B213.9B223.9B236.0B203.0B145.6B30.6B39.0B27.1B26.1B
Shares outstanding25.8M25.8M25.8M25.8M25.8M25.2M22.3M20.6M20.6M17.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations10.3B-13.5B4.14B8.81B53.2B95.7B-5.59B-8.11B-3.90B-4.09B
Capital spending-7.16B-12.6B-4.66B-18.5B-42.2B-54.5B-4.41B-3.70B-1.49B-6.39B
Free cash flow3.17B-27.1B-1.36B-9.72B9.89B39.0B-10.9B-11.8B-5.40B-10.5B
Cash from investing-21.9B-13.5B-19.1B-45.6B-60.5B-12.0B-10.5B-5.80B-6.72B
Cash from financing26.1B14.1B4.67B7.75B-5.95B18.3B17.8B11.4B4.51B
Share buybacks0155.0M1.36B67.5M18.2B17.5B5.70B
Change in cash7.66B-8.53B4.70B-5.55B16.7B27.9B729.7M-347.2M1.46B-6.16B